ImmuCell (ICCC)
(Real Time Quote from BATS)
$5.06 USD
+0.15 (3.06%)
Updated May 1, 2024 12:43 PM ET
NA Value
NA Growth NA Momentum NA VGMIndustry / Sector Report
Industry : Medical - Products
Zacks Industry Rank
Bottom 37% (157 out of 251)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 0.00 | 1.69 | 9.99 |
Current Quarter Estimate | NA | 5.88 | 60.00 |
Year Ago Quarter Estimate | NA | 4.88 | 52.54 |
Next Quarter Estimate | NA | 7.06 | 61.00 |
Next Year Estimate | NA | 39.92 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | NA | NA | NA |
Next Year | NA | NA | NA |
Last 5 Years | NA | NA | NA |
Next 5 Years | NA | NA | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -13.85 |
Price/Book (MRQ) | 1.52 | 1.90 |
Price/Cash Flow (MRFY) | NA | 10.67 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -33.05% | 12.53% |
Return on Equity (TTM) | -21.79% | 13.71% |
Debt to Equity (MRQ) | NA | 19.86 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.